Join Our 20,000+ Subscribers. Get Weekly News Sent To Your Email
Subscribe to our newsletter and stay updated on the latest Critical Care Medicine related news.
See Past Critical Care Newsletter issues

Subscribe to Newsletter

Frontline PARP inhibitor shrinks tumors in BRCA-positive breast patients

medicalxpress.com October 5, 2016

All 13 newly diagnosed breast cancer patients with BRCA mutations had their tumors shrink significantly when treated with a PARP inhibitor ahead of frontline presurgical chemotherapy in a pilot study at The University of Texas MD Anderson Cancer Center.

cancer chemotherapy oncology study tumors ultrasound

How I Perform Diaphragmatic Ultrasound in the ICU

Outcomes and inflammation changes in different types of immunocompromised patients with critically ill COVID-19 admitted to ICU

Pulmonary Barotrauma in COVID-19 Patients: Experience From a Tertiary University Hospital

Delirium and Weakness Acquired in the ICU: Individual and Combined Effects on 90-Day Mortality in Survivors of Critical Illness

Neonatal Lung Ultrasonography

The Beginner’s Guide to Intensive Care: A Handbook for Junior Doctors and Allied Professionals

Atlas of Interventional Pain Management

Irwin and Rippe’s Intensive Care Medicine

Abdominal Sepsis: A Multidisciplinary Approach

Cardiovascular Complications of COVID-19: Risk, Pathogenesis and Outcomes

The Song of the Cell: An Exploration of Medicine and the New Human

Hemodynamic Monitoring Using Echocardiography in the Critically Ill

The Washington Manual of Critical Care 4th Edition

Quick Reference to Critical Care

Bedside Procedures in the ICU

Trauma Team Dynamics: A Trauma Crisis Resource Management Manual

EKG/ECG Interpretation Made Easy

Evidence-Based Critical Care: A Case Study Approach

Clinical Examination Skills in the Adult Critically Ill Patient